Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
325.85
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $9.16 billion as of December 20, 2024. Its market cap has increased by 2.57% in one year.
Market Cap
9.16B
Enterprise Value
8.93B
1-Year Change
2.57%
Ranking
Category
Stock Price
$325.85
Market Cap Chart
Since December 23, 2019, Bio-Rad Laboratories's market cap has decreased from $11.10B to $9.16B, a decrease of -17.47%. That is a compound annual growth rate of -3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 9.15B | -1.55% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 57.32% |
| Dec 31, 2019 | 11.05B | -0.43% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Encompass Health | 9.52B |
| Exelixis | 9.51B |
| Charles River Laboratories International | 9.50B |
| Penumbra | 9.31B |
| Bio-Rad Laboratories | 9.17B |
| Masimo | 9.08B |
| Intra-Cellular Therapies | 8.85B |
| Henry Schein | 8.71B |